Arvinas, Inc. Files Definitive Proxy Statement for 2024 Annual Meeting

TL;DR

<b>Arvinas, Inc. has filed its definitive proxy statement for the 2024 Annual Meeting, detailing executive compensation and corporate governance matters for the 2023 fiscal year.</b>

AI Summary

ARVINAS, INC. (ARVN) filed a Proxy Statement (DEF 14A) with the SEC on April 16, 2024. Arvinas, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 16, 2024. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 5 Science Park, New Haven, CT 06511. The filing is related to the company's 2024 Annual Meeting. No filing fee was required for this statement.

Why It Matters

For investors and stakeholders tracking ARVINAS, INC., this filing contains several important signals. This DEF 14A filing provides shareholders with crucial information regarding the company's governance, executive compensation, and voting matters ahead of the annual meeting. Shareholders can review details on compensation structures, director nominations, and other proposals requiring their vote, enabling informed participation in corporate decision-making.

Risk Assessment

Risk Level: low — ARVINAS, INC. shows low risk based on this filing. The filing is a routine DEF 14A, providing standard disclosures without immediate financial or operational news, indicating a low level of immediate risk or opportunity.

Analyst Insight

Shareholders should review the proxy statement to understand executive compensation, board nominations, and voting proposals to make informed decisions at the upcoming annual meeting.

Key Numbers

• 2023-12-31 — Fiscal Year End (Reporting Period)
• 2024-04-16 — Filing Date (DEF 14A Submission)

Key Players & Entities

• ARVINAS, INC. (company) — Registrant
• 2024-04-16 (date) — Filing Date
• DEF 14A (document) — Form Type
• 20240529 (date) — Period of Report
• 0001655759-24-000052 (document) — Accession Number
• New Haven, CT 06511 (location) — Business Address
• 203-535-1456 (phone) — Business Phone

FAQ

Industry Context

Arvinas operates in the pharmaceutical preparations industry, focusing on developing novel protein degrader medicines.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, governing proxy statements.

What Investors Should Do

1. Review the proxy statement for details on director nominees and their qualifications.
2. Examine the executive compensation disclosures, including any proposed changes or advisory votes.
3. Understand all proposals being put forth for shareholder vote at the 2024 Annual Meeting.

Key Dates

• 2024-04-16: Filing of DEF 14A — Provides official disclosure for the 2024 Annual Meeting.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard disclosure document for annual meetings and does not represent a change from previous filings in terms of its nature, but provides updated information for the current year.

Filing Documents

• arvn-20240416.htm (DEF 14A) — 861KB
• arvn-20240416_g1.jpg (GRAPHIC) — 49KB
• arvn-20240416_g2.jpg (GRAPHIC) — 17KB
• arvn-20240416_g3.jpg (GRAPHIC) — 20KB
• arvn-20240416_g4.jpg (GRAPHIC) — 115KB
• arvn-20240416_g5.jpg (GRAPHIC) — 94KB
• arvn-20240416_g6.jpg (GRAPHIC) — 451KB
• arvn-20240416_g7.jpg (GRAPHIC) — 182KB
• 0001655759-24-000052.txt (&nbsp;) — 3574KB
• arvn-20240416.xsd (EX-101.SCH) — 1KB
• arvn-20240416_htm.xml (XML) — 84KB

From the Filing

arvn-20240416 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ____________________________________ Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under 240.14a-12 ARVINAS, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): x No fee required. o Fee paid previously with preliminary materials. o Fee computed on table in exhibit required by Item 25 (b) per Exchange Act Rules 14a-6 (i)(1) and 0-11. Table of Contents ARVINAS, INC. 5 Science Park 395 Winchester Ave. New Haven, CT 06511 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS To be held May 29, 2024 You are cordially invited to attend the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of Arvinas, Inc., which is scheduled to be held on Wednesday, May 29, 2024 at 8:30 a.m. Eastern Time. The Annual Meeting will be held as a virtual meeting only, via live audio webcast. You will not be able to attend the Annual Meeting in person. We believe that hosting a "virtual meeting" will enable greater stockholder attendance and participation from any location around the world. Only stockholders who owned common stock at the close of business on April 1, 2024 can vote at the Annual Meeting or any adjournment that may take place. At the Annual Meeting, the stockholders will consider and vote on the following matters: 1. Election of three Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders; 2. Hold an advisory vote on executive compensation; 3. Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and 4. Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting. You can find more information, including the nominees for directors, in the attached Proxy Statement. The board of directors recommends that you vote "FOR" each of the Class III director nominees (Proposal 1), and "FOR" each of Proposals 2 and 3. Instead of mailing a printed copy of our proxy materials to all of our stockholders, we provide access to these materials via the Internet. This reduces the amount of paper necessary to produce these materials as well as the costs associated with mailing these materials to all stockholders. Accordingly, on or about April 16, 2024, we will begin mailing a Notice of Internet Availability of Proxy Materials, or Notice, to all stockholders of record on our books at the close of business on April 1, 2024, the record date for the Annual Meeting, and we will post our proxy materials on the website referenced in the Notice. As more fully described in the Notice, stockholders may choose to access our proxy materials on the website referred to in the Notice or may request to receive a printed set of our proxy materials. In addition, the Notice and website provide information regarding how you may request to receive proxy materials in printed form by mail, or electronically by email, on an ongoing basis. If you are a stockholder of record, you may vote in one of the following ways: Vote over the Internet, by going to www.proxyvote.com (have your Notice or proxy card in hand when you access the website); Vote by Telephone, by calling the toll-free number 1-800-690-6903 (have your Notice or proxy card in hand when you call); Vote by Mail, if you received (or requested and received) a printed copy of the proxy materials, by completing, signing and dating the proxy card provided to you and returning it in the prepaid envelope provided to you; or Vote at the Annual Meeting. If your shares are held in "street name," that is, held for your account by a bank, broker or other nominee, you will receive instructions from the holder of record that you must follow for your shares to be voted. Table of Contents The rules a nd procedures applicable to the Annual Meeting, together with a list of stockholders of record for inspection for any purpose germane to the Annual Meeting will be available for the participating stockholders of record at www.virtualshareholdermeeting.com/ARVN2024. Your vote is very important. Whether or not you plan to attend the Annual Meeting in person, we urge you to take the time to vote your shares. By order of the Board of Direct

View Full Filing

View this DEF 14A filing on SEC EDGAR